The strong preliminary Q4 results indicate robust demand for DexCom's products, particularly its CGM sensors. Additionally, the company's international expansion efforts are contributing to increased sales, which supports a positive outlook for 2025. These factors are likely to boost investor confidence and drive the stock price up in the short term.